ID16091A - Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida - Google Patents

Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida

Info

Publication number
ID16091A
ID16091A IDP970478A ID970478A ID16091A ID 16091 A ID16091 A ID 16091A ID P970478 A IDP970478 A ID P970478A ID 970478 A ID970478 A ID 970478A ID 16091 A ID16091 A ID 16091A
Authority
ID
Indonesia
Prior art keywords
carbon atom
amino
configuration
pheniletanolaminotetralin
carboxamide
Prior art date
Application number
IDP970478A
Other languages
English (en)
Indonesian (id)
Inventor
Makio Kitazawa
Kosuke Okazaki
Tetsuro Tamai
Masaru Saito
Nobuyuki Tanaka
Hiroaki Kobayashi
Ken Kikuchi
Hideyuki Muranaka
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13386565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID16091(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of ID16091A publication Critical patent/ID16091A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Detergent Compositions (AREA)
IDP970478A 1996-02-19 1997-02-19 Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida ID16091A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6888596 1996-02-19

Publications (1)

Publication Number Publication Date
ID16091A true ID16091A (id) 1997-09-04

Family

ID=13386565

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970478A ID16091A (id) 1996-02-19 1997-02-19 Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida

Country Status (24)

Country Link
US (1) US6133266A (zh)
EP (1) EP0882704B1 (zh)
JP (1) JP3892045B2 (zh)
KR (1) KR100491633B1 (zh)
CN (1) CN1100032C (zh)
AT (1) ATE225767T1 (zh)
AU (1) AU725042B2 (zh)
BR (1) BR9707566B1 (zh)
CA (1) CA2245490C (zh)
CZ (1) CZ293974B6 (zh)
DE (1) DE69716242T2 (zh)
DK (1) DK0882704T3 (zh)
EA (1) EA002143B1 (zh)
ES (1) ES2184989T3 (zh)
HU (1) HU229400B1 (zh)
ID (1) ID16091A (zh)
MY (1) MY123853A (zh)
NO (1) NO323095B1 (zh)
NZ (1) NZ331445A (zh)
PL (1) PL186411B1 (zh)
PT (1) PT882704E (zh)
SG (1) SG72727A1 (zh)
TW (1) TW375604B (zh)
WO (1) WO1997030023A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8562098A (en) * 1997-08-19 1999-03-08 Kissei Pharmaceutical Co. Ltd. Phenylethanolaminotetralin derivatives and bronchodilators
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
FR2809725B1 (fr) * 2000-06-06 2004-05-07 Sanofi Synthelabo Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant
GB0029562D0 (en) 2000-12-04 2001-01-17 Novartis Ag Organic compounds
AU2004206161B2 (en) * 2003-01-22 2008-07-03 Kissei Pharmaceutical Co., Ltd. Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
JPWO2006054514A1 (ja) * 2004-11-19 2008-05-29 キッセイ薬品工業株式会社 神経因性疼痛の予防又は治療用医薬組成物
JPWO2006054513A1 (ja) * 2004-11-19 2008-05-29 キッセイ薬品工業株式会社 神経因性疼痛の予防又は治療剤
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
EP2501228A4 (en) * 2009-11-18 2013-11-13 Medicinova Inc TREATMENT OF ACUTE ASTHMA CRISIS AND REDUCTION OF THE PROBABILITY OF HOSPITALIZATION OF PATIENTS WITH SUFFERING
WO2011112499A1 (en) * 2010-03-08 2011-09-15 Medicinova, Inc. Compositions, methods, and devices for the treatment of dysmenorrhea
BR112012025703A2 (pt) * 2010-04-08 2016-07-05 Medicinova Inc métodos e composições para o tratamento de síndrome de intestino irritável

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107827D0 (en) * 1991-04-12 1991-05-29 Fujisawa Pharmaceutical Co New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL104567A (en) * 1992-02-03 1997-03-18 Fujisawa Pharmaceutical Co Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO1993018007A1 (en) * 1992-03-13 1993-09-16 Tokyo Tanabe Company Limited Novel carbostyril derivative

Also Published As

Publication number Publication date
PL186411B1 (pl) 2004-01-30
NZ331445A (en) 2000-01-28
JP3892045B2 (ja) 2007-03-14
KR19990082638A (ko) 1999-11-25
AU2001497A (en) 1997-09-02
NO323095B1 (no) 2007-01-02
BR9707566A (pt) 1999-07-27
ATE225767T1 (de) 2002-10-15
HU229400B1 (en) 2013-12-30
DK0882704T3 (da) 2003-02-17
PT882704E (pt) 2003-02-28
HUP9900621A3 (en) 1999-11-29
CN1216526A (zh) 1999-05-12
NO983777D0 (no) 1998-08-18
SG72727A1 (en) 2000-05-23
US6133266A (en) 2000-10-17
KR100491633B1 (ko) 2005-09-09
EA002143B1 (ru) 2001-12-24
CA2245490C (en) 2005-10-25
AU725042B2 (en) 2000-10-05
BR9707566B1 (pt) 2010-08-10
DE69716242T2 (de) 2003-07-24
NO983777L (no) 1998-10-19
HUP9900621A2 (hu) 1999-08-30
DE69716242D1 (de) 2002-11-14
EA199800644A1 (ru) 1999-02-25
CZ252398A3 (cs) 1998-12-16
EP0882704A1 (en) 1998-12-09
MY123853A (en) 2006-06-30
CN1100032C (zh) 2003-01-29
CA2245490A1 (en) 1997-08-21
WO1997030023A1 (fr) 1997-08-21
TW375604B (en) 1999-12-01
PL328530A1 (en) 1999-02-01
ES2184989T3 (es) 2003-04-16
EP0882704A4 (en) 2000-06-14
EP0882704B1 (en) 2002-10-09
CZ293974B6 (cs) 2004-09-15

Similar Documents

Publication Publication Date Title
ID16091A (id) Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida
ES2141137T3 (es) Agentes terapeuticos para la enfermedad de parkinson.
EA200000481A1 (ru) Производные гидроксамовой кислоты в качестве ингибиторов металлопротеаз матрикса (мпм)
PT93066A (pt) Processo para a preparacao de derivados heterociclicos contendo nucleos bengenicos fundidos com nucleos monoazotados substituidos e de composicoes farmaceuticas que os contem
ATE145906T1 (de) Benzamid-derivate
KR950700255A (ko) 피리딘카르복시이미드아미드 화합물 및 그 용도(pyridinecarboximidamide compounds and the use thereof)
WO1996005166A1 (fr) Derive d'amine substitue et composition medicamenteuse le contenant
NO913023L (no) Nye bicykliske aminosubstituerte forbindelser
NO984699L (no) Fenyletanolamino-tetralinkarboks-amid-derivater
EP0919233A4 (en) THERAPEUTIC AGENT FOR KIDNEY DISEASE
ES2070962T3 (es) N-hidroxi-dibenzo(b,e)oxepin-alquilaminas y -amidas de acido alcanoico, compuestos analogos heterociclicos relacionados, un procedimiento para su preparacion y su uso en la preparacion de medicamentos.
ES2060056T3 (es) Derivados de 3-isoxazolonas, su preparacion y su utilizacion en terapeutica.